APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases

R Fernández-Calle, SC Konings… - Molecular …, 2022 - Springer
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …

[HTML][HTML] Sex hormone fluctuation and increased female risk for depression and anxiety disorders: from clinical evidence to molecular mechanisms

M Kundakovic, D Rocks - Frontiers in neuroendocrinology, 2022 - Elsevier
Women are at twice the risk for anxiety and depression disorders as men are, although the
underlying biological factors and mechanisms are largely unknown. In this review, we …

Endogenous and exogenous estrogen exposures: how women's reproductive health can drive brain aging and inform Alzheimer's prevention

S Jett, N Malviya, E Schelbaum, G Jang… - Frontiers in Aging …, 2022 - frontiersin.org
After advanced age, female sex is the major risk factor for late-onset Alzheimer's disease
(AD), the most common cause of dementia affecting over 24 million people worldwide. The …

Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's disease

C Barth, A Crestol, AMG de Lange… - The Lancet Diabetes & …, 2023 - thelancet.com
Despite widespread sex differences in prevalence and presentation of numerous illnesses
affecting the human brain, there has been little focus on the effect of endocrine ageing. Most …

Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia

M Nerattini, S Jett, C Andy, C Carlton… - Frontiers in aging …, 2023 - frontiersin.org
Introduction Despite a large preclinical literature demonstrating neuroprotective effects of
estrogen, use of menopausal hormone therapy (HT) for Alzheimer's disease (AD) risk …

Mechanisms of sex differences in Alzheimer's disease

C Lopez-Lee, ERS Torres, G Carling, L Gan - Neuron, 2024 - cell.com
Alzheimer's disease (AD) and the mechanisms underlying its etiology and progression are
complex and multifactorial. The higher AD risk in women may serve as a clue to better …

[HTML][HTML] Menopause—Biology, consequences, supportive care, and therapeutic options

SR Davis, JA Pinkerton, N Santoro, T Simoncini - Cell, 2023 - cell.com
Menopause is the cessation of ovarian function, with loss of reproductive hormone
production and irreversible loss of fertility. It is a natural part of reproductive aging. The …

From menopause to neurodegeneration—molecular basis and potential therapy

YJ Cheng, CH Lin, HY Lane - International journal of molecular sciences, 2021 - mdpi.com
The impacts of menopause on neurodegenerative diseases, especially the changes in
steroid hormones, have been well described in cell models, animal models, and humans …

Association of reproductive history with brain MRI biomarkers of dementia risk in midlife

E Schelbaum, L Loughlin, S Jett, C Zhang, G Jang… - Neurology, 2021 - AAN Enterprises
Background and Objectives To examine associations between indicators of estrogen
exposure from women's reproductive history and brain MRI biomarkers of Alzheimer disease …

In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology

L Mosconi, M Nerattini, DC Matthews, S Jett, C Andy… - Scientific Reports, 2024 - nature.com
Abstract 17β-estradiol, the most biologically active estrogen, exerts wide-ranging effects in
brain through its action on estrogen receptors (ERs), influencing higher-order cognitive …